Cardiac Safety of Osimertinib: A Review of Data

Post hoc analysis of data (2 studies and the clinical trial program) did not suggest a causal relationship between osimertinib and cardiac failure, however, as left ventricular ejection fraction (LVEF) decreases occurred cardiac monitoring and baseline LVEF assessment are advised

Source:

Journal of Clinical Oncology